XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments and Risk Management (Tables)
9 Months Ended
Jun. 26, 2021
Fair Value Disclosures [Abstract]  
Fair value of the Partnership's derivative instruments and their location in the condensed consolidated balance sheets

The following summarizes the fair value of the Partnership’s derivative instruments and their location in the condensed consolidated balance sheets as of June 26, 2021 and September 26, 2020, respectively:

 

 

 

As of June 26, 2021

 

 

As of September 26, 2020

 

Asset Derivatives

 

Location

 

Fair Value

 

 

Location

 

Fair Value

 

Derivatives not designated as

   hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Commodity-related derivatives

 

Other current assets

 

$

26,076

 

 

Other current assets

 

$

1,066

 

 

 

Other assets

 

 

532

 

 

Other assets

 

 

461

 

 

 

 

 

$

26,608

 

 

 

 

$

1,527

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives

 

Location

 

Fair Value

 

 

Location

 

Fair Value

 

Derivatives not designated as

   hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Commodity-related derivatives

 

Other current liabilities

 

$

6,049

 

 

Other current liabilities

 

$

2,684

 

 

 

Other liabilities

 

 

1,013

 

 

Other liabilities

 

 

 

 

 

 

 

$

7,062

 

 

 

 

$

2,684

 

Reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs

The following summarizes the reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs:

 

 

 

Fair Value Measurement Using Significant

Unobservable Inputs (Level 3)

 

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

June 26, 2021

 

 

June 27, 2020

 

 

 

Assets

 

 

Liabilities

 

 

Assets

 

 

Liabilities

 

Beginning balance of over-the-counter options

 

$

 

 

$

 

 

$

419

 

 

$

 

Beginning balance realized during the period

 

 

 

 

 

 

 

 

(419

)

 

 

 

Contracts purchased during the period

 

 

2,675

 

 

 

182

 

 

 

 

 

 

 

Change in the fair value of outstanding contracts

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance of over-the-counter options

 

$

2,675

 

 

$

182

 

 

$

 

 

$

 

Effect of the Partnership's derivative instruments on the condensed consolidated statements of operations

The effect of the Partnership’s derivative instruments on the condensed consolidated statements of operations for the three and nine months ended June 26, 2021 and June 27, 2020 are as follows:

 

 

 

Three Months Ended June 26, 2021

 

 

Three Months Ended June 27, 2020

 

Derivatives Not Designated

as Hedging Instruments

 

Unrealized Gains (Losses)

Recognized in Income

 

 

Unrealized Gains (Losses)

Recognized in Income

 

 

 

Location

 

Amount

 

 

Location

 

Amount

 

Commodity-related derivatives

 

Cost of products sold

 

$

11,139

 

 

Cost of products sold

 

$

861

 

 

 

 

Nine Months Ended June 26, 2021

 

 

Nine Months Ended June 27, 2020

 

Derivatives Not Designated

as Hedging Instruments

 

Unrealized Gains (Losses)

Recognized in Income

 

 

Unrealized Gains (Losses)

Recognized in Income

 

 

 

Location

 

Amount

 

 

Location

 

Amount

 

Commodity-related derivatives

 

Cost of products sold

 

$

17,632

 

 

Cost of products sold

 

$

(1,077

)

 

Fair Value of the Partnership's Senior Notes .  Based upon quoted market prices (a Level 1 input), the fair value of the Senior Notes (also defined below in Note 10) of the Partnership are as follows:

 

 

As of

 

 

 

June 26,

 

 

September 26,

 

 

 

2021

 

 

2020

 

5.5% senior notes due June 1, 2024

 

$

 

 

$

531,563

 

5.75% senior notes due March 1, 2025

 

 

 

 

 

255,625

 

5.875% senior notes due March 1, 2027

 

 

369,250

 

 

 

360,063

 

5.0% senior notes due June 1, 2031

 

 

664,625

 

 

 

 

 

 

$

1,033,875

 

 

$

1,147,251